°¡Ãµ´ë ±æº´¿ø Ç÷¾×Á¾¾ç³»°úÀÇ ÀÌÀçÈÆ ±³¼ö(»çÁø)°¡ ¹Ì±¹Ç÷¾×ÇÐȸ ÀâÁö¿¡ ÃÖ±Ù °ÔÀçµÈ ÃÖ±Ù ¾Æ½Ã¾Æ 7°³±¹ °øµ¿ ¿¬±¸ÀÎ ‘¾Æ½Ã¾Æ ´Ù¹ß¼º°ñ¼öÁ¾ÀÇ ÀÓ»óÀû Ư¡°ú ¿¹ÈÄÀÎÀÚ¿¡ °üÇÑ ¿¬±¸(Clinical profiles of multiple myeloma in Asia-an Asian Myeloma Network (AMN) study)’·Î ±³½ÅÀúÀÚ·Î Âü¿©Çß´Ù.
ÀÌ ±³¼ö´Â ´Ù¹ß¼º °ñ¼öÁ¾ ¿¬±¸¿Í °ü·ÃÇØ Çѱ¹ÀÇ À¯ÀÏÇÑ ‘International Myeloma Working Group(IMWG)’ ȸ¿øÀÌÀÚ ±¹Á¦ °ñ¼öÁ¾ Àç´ÜÀÇ Æ¯º° ÀÚ¹®À§¿øÀÌ°í ¾Æ½Ã¾Æ °ñ¼öÁ¾ ³×Æ®¿öÅ©(Asian Myeloma Network)ÀÇ ¸®´õ·Î È°µ¿ÇÏ°í ÀÖ´Ù.
À̹ø ³í¹®Àº ¾Æ½Ã¾Æ¿¡¼ ±ÞÁõÇÏ°í ÀÖ´Â ´Ù¹ß¼º °ñ¼öÁ¾ÀÇ Æ¯Â¡À» ºÐ¼®ÇÑ Ã¹ ¹ø° ¿¬±¸·Î¼ ÇâÈÄ ¼ö¸¹Àº ¿¬±¸¿¡¼ ÀοëµÉ ±â³äºñÀûÀÎ ³í¹®À¸·Î Æò°¡ ¹Þ°í ÀÖ´Ù. À̹ø ¿¬±¸´Â ±¹Á¦ °ñ¼öÁ¾ Àç´Ü (International Myeloma Foundation)ÀÌ ÈÄ¿øÇß´Ù.
ÇÑÆí ÀÌ ±³¼ö´Â Áö³ 3¿ù Çѱ¹ÀÎ ´Ù¹ß¼º°ñ¼öÁ¾ÀÇ À¯ÀüÀû Ư¡À» ºÐ¼®ÇÑ ³í¹®(Chromosome 13 deletion and hypodiploidy on conventional cytogenetics are robust prognostic factors in Korean multiple myeloma patients: web-based multicenter registry study)À» ±³½ÅÀúÀڷμ ÃâÆÇÇÏ´Â µî È°¹ßÇÑ Çмú È°µ¿À» ÇÏ°í ÀÖ´Ù. ÀÌ ³í¹®Àº ±³¼öÀÇ 200¹ø° SCI ³í¹®ÀÌ´Ù.